You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
This volume reviews current and potential future therapies for arrhythmias. It is a highly practical guide for the use of pharmaceuticals in the management of the discipline, and has been written in a simple quick-access format. Antiarrhythmic Drugs builds on the current understanding of pathophysiological mechanisms and insights gained from previous studies of therapeutic interventions. It is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis.
The paradigm for atrial fibrillation (AF) management has changed significantly in recent years. A new era has begun for the prevention of one of the most tremendous complication of AF, stroke. Prevention of ischemic stroke in AF patients with oral anticoagulants represents a huge challenge because of the narrow therapeutic change of these drugs, interindividual and intraindividual variability, and the unsatisfactory time in therapeutically range (TTR) with this type of medication. New guidelines have emerged as a result of new mechanisms for initiation and perpetuation for pharmacotherapy to cure AF and trials with new classes of antithrombotic drugs are ongoing. The treatment of AF is still in its infancy, but recent research is revealing how it can be applied with optimal efficacy. This book assists trainees, recertifying physicians, practicing physicians and other professional staff in internal medicine, cardiology, emergency medicine, and clinical pharmacology to apply new diagnostic tools for selecting the best treatment options for AF patients.
The ESC Handbook on Cardiovascular Pharmacotherapy, based on the most recent guidelines in cardiovascular pharmacology, and containing a comprehensive A-Z formulary of common and less commonly used cardiac drugs and drug groups, provides practical and accessible guidance on all areas of drug prescribing.
Maximise your exam success with this essential revision guide. The fourth edition of Oxford Assess and Progress: Clinical Medicine, features over 600 Single Best Answer questions. Packed with new and updated questions written by experienced doctors, this revision tool is an authoritative guide for finals and the UKMLA. Questions on core clinical topics are accompanied by extensive feedback, which explains not only the rationale of the correct answer, but why the other options are incorrect. Further reading resources and updated cross-references to the eleventh edition of Oxford Handbook of Clinical Medicine expand your revision further. Progess to exam success with the fourth edition of Oxford Assess and Progress: Clinical Medicine.
This book provides a comprehensive overview of cardiovascular diseases (CVDs) and associated conditions. It is organized into three sections on “Cardiovascular Pathophysiology”, “Cardiovascular Diagnostics”, and “Cardiovascular Treatments”. Chapters address such topics as the role of obesity in CVD, cardiotoxicity, cardio-oncology, CVD in different disease states, modalities for detecting CVD, interventional strategies to prevent or treat CVD, and much more.
Life-Threatening Effects of Antipsychotic Drugs describes in detail more than 20 life-threatening effects associated with antipsychotics, presents the best available data on their incidence and case fatality, and gives comprehensive advice on diagnosis, management and preventive strategies. In addition, the book discusses the benefit of antipsychotic medication in a range of therapeutic indications, and demonstrates the gain in life-expectancy associated with clozapine use in severe mental illness despite its serious, potentially life-threatening adverse effects. - Covers cardiovascular, neurological, muscular, hematological, gastrointestinal, autonomic and metabolic effects - Gives advice on risk factors, confounding diagnoses and measures to minimise seriousness - Discusses clozapine rechallenge after each of its serious adverse reactions - Makes suggestions for optimum management of somatic disease in those with severe mental illness, to improve life-expectancy - Includes data on post-mortem considerations